Our products are supported by independent COA and HPLC testing from laboratories in US and China and have been supplied to customers across North America.
We offer a portfolio of more than 100 peptide products. Our pharmaceutical-grade lyophilization facility is designed and constructed in accordance with GMP requirements, with a capacity of up to 1.5 million vials per month.
We support research-grade and GMP-grade products, aseptic lyophilized formulations, and pilot-to-commercial-scale production. Standard projects start from 2,000 vials, with lead times as short as approximately one week for production-ready projects.


Tirzepatide






BPC-157
GHK-Cu
Epithalon, Retatrutide and 50+ More Peptides Available










